SGRY

Surgery Partners, Inc.

SGRY · CIK 1638833 · Annual (10-K) · Last 8 years

Financial Trends

Revenue
20182025
Net Income−$78M
20182025
Operating CF$274M
20182025
Free Cash Flow$196M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue————————
Cost of Revenue——————$0.4B$0.4B
Gross Profit————————
R&D Expense————————
SG&A Expense————————
Operating Income$0.4B$0.3B$0.3B$0.3B$0.3B$0.2B$0.2B$0.1B
Net Income$-0.1B$-0.2B$-0.0B$-0.1B$-0.1B$-0.1B$-0.0B$-0.1B
EPS (Basic)$-0.61$-1.33$-0.09$-0.59$-1.12—$-0.59$-3.25
EPS (Diluted)$-0.61$-1.33$-0.09$-0.59$-1.12—$-0.59$-3.25

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$8.1B$7.9B$6.9B$6.7B$6.1B$5.4B$5.0B$4.7B
Current Assets$1.2B$1.1B$0.9B$0.9B$0.9B$0.8B$0.5B$0.6B
Cash & Equivalents$0.2B$0.3B$0.2B$0.3B$0.4B$0.3B$0.1B$0.2B
Total Liabilities————————
Current Liabilities$0.6B$0.6B$0.5B$0.5B$0.5B$0.6B$0.4B$0.3B
Stockholders' Equity$1.7B$1.8B$2.0B$2.0B$1.1B$0.1B$0.3B$0.4B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.3B$0.3B$0.3B$0.2B$0.1B$0.2B$0.1B$0.1B
Investing Cash Flow$-0.2B$-0.5B$-0.2B$-0.3B$-0.3B$-0.1B$-0.1B$-0.1B
Capital Expenditures$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.1B$0.0B
Financing Cash Flow$-0.1B$0.3B$-0.2B$0.0B$0.3B$0.1B$-0.1B$-0.0B
← Companies